Available now from CELLSCRIPT?: New INCOGNITO? kits to make N1-methyl-pseudouridine (N1meΨ)- and pseudouridine (Ψ)-containing RNA or mRNA. - INCOGNITO? T7 mScript? mRNA Production Systems contain everything needed to make N1meΨ- or Ψ-containing Cap1 mRNA, including in vitro transcription reagents plus ScriptCap? Capping Enzyme, ScriptCap? 2’-O-Methyltransferase, and A-Plus? Poly(A) Polymerase. ? - INCOGNITO? T7-FlashScribe? Transcription Kits are for in vitro transcription of N1meΨ- or Ψ-containing RNA. - All kits above come with a label license to use them for internal research use under the University of Pennsylvania’s modified mRNA technologies patents. Visit our website for more information at cellscript.com.
关于我们
CELLSCRIPT? provides products and technologies for making and using RNA for translation in cells for clinical research and therapeutics, including RNA comprising pseudouridine (Ψ) and other modified nucleosides covered by patents licensed from the University of Pennsylvania. Products include enzymes and kits for in vitro transcription, co-transcriptional or post-transcriptional 5’ RNA capping, and 3’ RNA polyadenylation.
- 网站
-
https://www.cellscript.com/
CELLSCRIPT的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Madison,WI
- 类型
- 私人持股
- 创立
- 2007
地点
-
主要
726 Post Rd
US,WI,Madison,53713
CELLSCRIPT员工
动态
-
Our mission at CELLSCRIPT? is to provide the best products and technologies for making and using RNA for translation in cells for clinical research and therapeutics. Since our founding in 2007, we have been committed to delivering high-quality, reliable reagents trusted by scientists in academic, governmental, biotech, and pharmaceutical organizations. As the RNA field evolves, we are dedicated to introducing new products to continue meeting our customers’ needs. Follow our page to be among the first to get news and updates about our products and new technologies or visit our website at cellscript.com.